계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
COYOTE
company
About
Coyote Bioscience is the developer of point-of-care molecular diagnostics, pathogen detection, and life science tools.
- 1 - 10
Details
- Last Funding Type
- Series E
- Last Funding Money Raised
- ¥50M
- Industries
- Biotechnology,Health Diagnostics,Medical
- Founded date
- Dec 4, 2009
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥130M
COYOTE has raised a total of
¥130M
in funding over 2 rounds. Their latest funding was raised on
Mar 28, 2019 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 28, 2019 | Series E | ¥50M | 3 | — | — | Detail |
| Jul 31, 2018 | Series D | ¥50M | 1 |
|
— | Detail |
| Sep 22, 2017 | Series C | ¥30M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
6
COYOTE is funded by 6 investors.
Shanghai Real Estate Asset Management
and Jilin Yanglao Jijin
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series D |
|
|
— | Series E |
|
|
— | Series E |
|
|
— | Series E |
|
|
— | Series C |
New Founder
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
